試す 金 - 無料
Ireland Provides an Easy Market Into Europe
Bio Spectrum
|December 2016
Sahajanand Medical Technologies (SMt) is developer and manufacturer of minimal-ly invasive coronary stent systems in India and supplies to around 60 countries in Europe, Asia, MENA and Latin America. the company has received numerous awards for its breakthrough innovations and quality, that have led to thinner and more flexible DES (drug-eluting stents) with good long term clinical results.
SMT is establishing its European headquarters, including Research, Development and Innovation centre in Ireland. We chat with SMt’s Western European Head, Gaurav Goel, to know more about it.
Gaurav Goel
Western European Head, Sahajanand Medical Technologies (SMT)
Q: What is the rationale behind setting up an office in Ireland?
A: Ireland is well known as the medical device hub of the world. 15 of the top 20 global medtech companies operate in Ireland. Ireland provides a complete eco-system in terms of infrastructure, highly skilled manpower, raw material and capital goods suppliers at close proximity. When SMT wanted to expand into the European market, it scouted various countries in Europe. The major thrust was to find out a suitable country where we could address our multiple requirements and Ireland was our answer. Ireland fits perfectly into our short term and long term goals. We look forward to bringing together our Indian talent along with the high skilled manpower available in Ireland to become a major global medical device player.
Q: Could you please throw some light on SMt’s product portfolio? What are your areas of focus as far as product services are concerned?
このストーリーは、Bio Spectrum の December 2016 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Bio Spectrum からのその他のストーリー
Bio Spectrum
S&T Minister inaugurates Biotechnology Research and Innovation Council (BRIC) Secretariat
The Union Minister of (Independent State Charge) for Science and Technology (S&T) Dr Jitendra Singh recently inaugurated the Biotechnology Research and Innovation Council (BRIC) Secretariat by unveiling the inaugural curtain, marking the official opening of a new milestone in India's biotechnology journey.
1 min
February 2026
Bio Spectrum
US announces $50 B in awards to strengthen rural healthcare
The Centers for Medicare & Medicaid Services (CMS) has announced that all 50 states will receive awards under the Rural Health Transformation Program, a $50 billion initiative established under President Trump's Working Families Tax Cuts legislation (Public Law 119-21) to strengthen and modernise healthcare in rural communities across the country.
1 min
February 2026
Bio Spectrum
WHO unveils Traditional Medicine Global Library
At the second WHO Global Summit on Traditional Medicine, jointly organised with the Government of India, concluding recently in New Delhi, WHO unveiled the Traditional Medicine (TM) Global Library (GL), a first-of-its-kind digital platform consolidating 1.6 million resources on TM, from scientific studies to indigenous knowledge.
1 min
February 2026
Bio Spectrum
Telangana sets global ambition with Life Sciences Policy 2026-30 targeting $25 B investments
The Government of Telangana unveiled its Next-Gen Life Sciences Policy 2026-30 at the World Economic Forum Annual Meeting in Davos, signalling the State's intent to play a far more consequential role in shaping the future of global healthcare, advanced therapeutics, and sustainable bio-manufacturing.
1 min
February 2026
Bio Spectrum
WHO reveals major equity gaps in human genomics research
The World Health Organization (WHO) has published a new global analysis of human genomics in clinical research, covering more than three decades of studies registered between 1990 and 2024.
1 min
February 2026
Bio Spectrum
Biotium launches GlycoLiner Cell Surface Glycoprotein Labeling Kits
US-based Biotium, a leading innovator in fluorescent dyes and life science reagents, has announced the launch of GlycoLiner Cell Surface Glycoprotein Labeling Kits for rapid, selective, and covalent labeling of cell surface glycoproteins.
1 min
February 2026
Bio Spectrum
Bruker consolidates ownership of TOFWERK in expansion of mass spectrometry portfolio
Bruker Corporation has announced the acquisition of an additional 60 per cent ownership stake in TOFWERK AG, a Switzerland-based innovator in ultra-fast time-of-flight (TOF) mass spectrometry technology for small molecule applied markets, consolidating Bruker's ownership to 100 per cent.
1 min
February 2026
Bio Spectrum
India & Australia develop precision nano-injection platform for breast cancer drug delivery
Researchers from the Indian Institute of Technology Madras (IIT-M), Monash University and Deakin University, Australia, have developed a cutting-edge nano-injection drug delivery platform that has the potential to make breast cancer treatment safer and more effective.
1 min
February 2026
Bio Spectrum
Agilent opens India Refurbishment Centre in Manesar
Agilent Technologies Inc., a global leader in life sciences, diagnostics, and applied chemical markets, has announced the inauguration of its India Refurbishment Centre at its LEED Platinum-certified facility in Manesar, Haryana.
1 min
February 2026
Bio Spectrum
Yashoda Medicity appoints Dr Rajinder Kumar as Unit Head, Department of Neurosurgery
Yashoda Medicity, one of the leading hospitals in the Delhi NCR, has appointed Prof. Dr Rajinder Kumar as Principal Director & Unit Head, Neurosurgery at the Yashoda Institute of Neurosciences.
1 min
February 2026
Translate
Change font size
